Is Kwality Pharmaceuticals Limited a good investment? Kwality Pharmaceuticals Limited (KPL.BO) is currently trading at 1404.10 INR.
In terms of valuation, the stock trades at a P/E ratio of 26.14. This valuation is generally in line with the broader market.
Earnings Schedule: Kwality Pharmaceuticals Limited is expected to release its next earnings report on May 18, 2026.
No, it does not currently pay a dividend.
Kwality Pharmaceuticals Limited is classified as a Stock.
The next earnings date is projected to be May 18, 2026. The company currently has a trailing EPS of 54.48.
Kwality Pharmaceuticals Limited, together with its subsidiary, manufactures finished pharmaceutical formulations in India and internationally. The company offers its products in various dosage forms, including liquid orals, powder for oral suspension, dry syrups, tablets, capsules, sterile powder for injections, small volume parentals (liquid and lyophilized), pre filled syringes, ointments and creams, ophthalmic preparations, eye/ear drops, sanitizers, suppositories, injectable vials and ampoules, lyophilized products, syrups, daunorubicin, and various other categories such as general, beta-lactam, cephalosporins, cytotoxic (oncology), and biological. It also provides intermediates, chemicals, extracts, alkaloids, toilet requisites, beverages, and other medical preparations. Kwality Pharmaceuticals Limited was incorporated in 1983 and is based in Amritsar, India.
| Year | Total Dividends |
|---|---|
| 2017 | 0.60 INR |
| Jan. 5, 2017 | 0.6000 |
Yearly aggregated dividends
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion